Cancer Diagnostics Market : Gross Margin, Cost, and Revenue Forecasts to 2032

 The global cancer diagnostics market is projected to expand steadily at a CAGR 7.1% value, during the forecast period 2022-2032. In the year 2022, the market size is projected to expand and gain a global market valuation of US$ 191 Billion. Considering this increasing growth and demand in the global market, the cancer diagnostics market is expected to reach US$ 379 Billion by 2032.

Technological advancements in various fields such as biopsy, imaging, biomarkers and endoscopy, rising prevalence of cancer, increase in government initiatives for creating awareness, rapidly increase in geriatric population, and growing government funding are key factors driving the growth of the cancer diagnostics market.

Timely detection of cancer requires suitable diagnostic tests to screen the immunosuppressed population which is at moderate risk of cancer, particularly for lung cancer, cervical cancer, breast cancer, prostate cancer, colon cancer and melanoma. Growing awareness of early signs and symptoms of cancer among physicians and other healthcare professionals as well as among the general population supplements the growth of cancer diagnostics.

Inclusion of cancer screening tests in National Cancer Screening Programs is another major factor expected to fuel the demand for cancer diagnostics. Introduction of regular mammography into national cancer programs by major developed countries where the incidence of breast cancer is high that is leading towards increasing adoption of cancer diagnostics in developed region.

For instance, the U.S. government has included the National Mammography Program in its national cancer screening programs. The government of Australia is taking initiative by conducting 3 cancer screening programs such as the National Cervical Screening Program, BreastScreen Australia and the National Bowel Cancer Screening Program. Similarly, most of the countries in Europe are continuously adopting HPV DNA screening for cervical cancer as a part of national cervical cancer programs.

Short-term Negative Impact Likely Due to COVID-19

The cancer diagnostics market is expected to experience short-term negative growth owing to a reduction in the cancer diagnosis procedures and adoption rate in developed and emerging countries. COVID-19 has impacted the landscape of cancer diagnostics. This has affected demand in various fronts, from prevention to screening and diagnosis, palliative care, treatment, and patient follow-up, to logistics and supplies of cancer diagnostic tests kits and other essential commodities.

Nonetheless after a period of muted growth, the market is poised to recover as economies return to normalcy. As per FMI, the rising incidence of lung cancer is attributable for over 19% of sales in the market.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-1090

Key Takeaways from Cancer Diagnostics Market Study

  • The rising incidence of cancer will fuel the demand for cancer diagnostics, enabling the market register 8.5% CAGR between 2021 and 2022
  • Increasing cases of cancer in the U.S. accounts for 84% of demand in North America
  • Increasing healthcare spending will enable the U.K. market register over 5% y-o-y growth in 2021
  • Favorable reimbursement policies will support growth in France and Germany
  • Expansion of the healthcare sector will support growth in Japan and South Korea

“Advancements in cancer diagnostics and rising prevalence of cancer are expected to aid growth of cancer diagnostics. A majority of leading players in cancer diagnostic market are adopting strategic partnerships to sustain the increasing competitive pressure,” says the FMI Analyst

Who is Winning?

Partnerships between cancer diagnostic assay kits developers, instrument manufacturers and technology licensers are often intended to increase the consumer base.

For instance, in March 2021, Illumina, Inc. signed a partnership agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits by using Illumina’s NextSeq 550Dx sequencing platform for cancer.

In June 2020, Thermo Fisher Scientific signed an agreement with Daiichi Sankyo to Co-launch a companion diagnostic for patients with non-small cell lung cancer for identifying Her2 gene mutations using the Oncomine Dx target test.

Cancer Diagnostics Market by Category

Test Type

  • Tumour Biomarkers Tests
    • PSA Tests
    • CTC Tests
    • AFP Tests
    • CA Tests
    • HER2 Tests
    • BRCA Tests
    • ALK Tests
    • CEA Tests
    • EGFR Mutation Tests
    • KRAS Mutation Tests
    • Others
  • Imaging
    • Ultrasound
    • Mammography
    • MRI Scan
    • PET Scan
    • CT Scan
    • SPECT & Others
  • Biopsy
    • Needle Biopsy
    • Endoscopic Biopsy
    • Bone Marrow Biopsy
    • Others
  • Liquid Biopsy
  • Immunohistochemistry
  • In Situ Hybridization

Indication

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Melanoma
  • Blood Cancer
  • Prostate Cancer
  • Ovarian Cancer
  • Stomach Cancer
  • Liver Cancer
  • Others

End-user

  • Hospital Associated Labs
  • Independent Diagnostic Laboratories
  • Diagnostic Imaging Centers
  • Cancer Research Institutes
  • Others

Comments

Post a Comment

Popular posts from this blog

Dental Burs Market | Growth Opportunities, Business Insights And Forecast To 2032

With an anticipated market value of over  US$ 139.2 Million as of 2022 , the demand for  dental burs market size   is expected to experience a significant CAGR growth value of about  7.8%  from 2022 to 2032, reaching an estimated market value of  US$ 295.6 Million in 2032.  Specialty clinics will account for a significant 40.1% of the end-user sector of the global market in 2021, according to forecasts from Future Market Insights. Over the last two decades, the frequency of dental disorders such as gum disease, dental crack, periodontal disease, and dental cavities has been on the rise. This is expected to boost the worldwide dental burs market. Dentin removal, cutting hard tissues, implantology, cavity preparation and other procedures need the use of dental burs, which are frequently made of stainless steel, tungsten carbide, and diamond grit. The most common and preventable dental condition is dental caries. This factor is associated with changing lifestyles as well as individual eat
Read more

Commercial Helicopter Market Key Players, SWOT Analysis, Key Indicators & Forecast By 2032

  The global   commercial helicopter market size  is expected to reach a valuation of US$ 11.5 Bn by 2032, with the market expanding at a positive CAGR of 6.4% from 2022 to 2032. Valued at US$ 5.9 Bn in 2021, the target market is expected to reach an estimated US$ 6.2 Bn in 2022. Key Takeaways: The commercial helicopter market in the United States will grow at 5.5% CAGR, reaching US$ 3.9 Bn by 2032. In Europe, the commercial helicopter market is predicted to expand at a CAGR of 6%, arriving at a value of US$ 2.8 Bn during the assessment period. By type, the light commercial helicopter segment is anticipated to register a CAGR of 6% during 2022-2032. Based on application, the public safety and law enforcement segment is leading the market with a CAGR of 5.5% during the forecast period. The elevated need for  commercial helicopters  in emergency services, VIP transport, military and defense activities, and oil and gas rigs as well as the replacement of older fleets propel the growth of t
Read more

Electrophoresis Market: Creating Opportunity, Demands & Supply, Value Chain & Process- upto 2032

Global demand for  electrophoresis market share  is set to increase at a  4.7%  CAGR from 2022 to 2032, with an estimated market value of around  US$ 2.2 Bn  as of 2022. As per Future Market Insights’ projections, reagents and consumables held about  48.7%  of the   global market share in 2021. Electrophoresis has developed into one of the most universal analytical practices in the life sciences sector. Cutting-edge technology and automation in this process offers unparalleled reproducibility and ease of use and decreased hands-on time. Furthermore, convenience of automated systems over manual systems and obtainability of prompt results are anticipated to fuel the electrophoresis market. The growing prevalence of cancer and expansion in research and development will drive demand, providing a vast potential for electrophoresis players to address chronic illness. Healthcare establishments are promptly adopting devices such as electrophoresis equipment to carry out biological research and
Read more